Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...
A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm. The post New state-of-the-art test identifies ...
Annual Congress was host to a renal cell carcinoma abstract session. Dr. Huebner-Resch presented her team’s initial real-world experience using [89 Zr]Zr-girentuximab PET/CT in the routine evaluation ...
Stage 1 mixed cellularity Hodgkin lymphoma is often highly treatable, and many patients achieve long-term remission after frontline therapy. Advances in chemotherapy, radiation techniques and targeted ...
Primary tracheal malignancies are extremely rare, accounting for less than 0.1 per cent of all cancers, with an incidence of 2–3 cases per million per year ...
Partnership integrates pet insurance access into the Hands2Paws platform, helping owners prepare for unexpected ...
Barclays 28th Annual Global Healthcare Conference March 12, 2026 8:00 AM EDTCompany ParticipantsMark Stolper - Executive VP ...
Annual Congress was host to a renal cell carcinoma abstract session. Dr. David Liu presented results from ZIRCON-X, a post-hoc analysis of the phase 3 ZIRCON study evaluating the potential impact of ...
In the early 1970s, geography itself shaped the odds of surviving a heart attack in the Central Valley. From Los Angeles to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results